Garenoxacin-induced increase of CD11b expression on human polymorphonuclear neutrophils does not affect phagocytosis and killing of Staphylococcus aureus

Journal of Infection and Chemotherapy

Volumn 17, Issue 2, 2011, Pages 291-296

  Grüger, Thomas ^a   Reiners, Ana Lena ^a   Schnitzler, Norbert ^a   Brandenburg, Kerstin ^a   Zündorf, Josef ^a  

^a Federal Institute for Drugs and Medical Devices BfArM   (Germany)

Author keywords

CD11b; Garenoxacin; Polymorphonuclear leukocyte (PMN); Staphylococcus aureus

Indexed keywords

CD11B ANTIGEN; CIPROFLOXACIN; GARENOXACIN; MOXIFLOXACIN; NORFLOXACIN;

ANTIGEN EXPRESSION; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INHIBITION KINETICS; MALE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; RESPIRATORY BURST; STAPHYLOCOCCUS AUREUS;

EID: 79955926343     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-010-0099-8     Document Type: Article

References (15)

1. Fritsche TR, Sader HS, Jones RN. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004). Diagn Microbiol Infect Dis. 2007;58:19-26.
2. Ince D, Zhang X, Silver C, Hooper DC. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone. Antimicrob Agents Chemother. 2002;46:3370-80. (Pubitemid 35192899)
3. Schnitzler N, Haase G, Podbielski A, Lütticken R, Schweizer KG. A co-stimulatory signal through ICAM-β2 integrin-binding potentiates neutrophil phagocytosis. Nat Med. 1999;5:231-5. (Pubitemid 29068533)
4. Labro MT. Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"? Clin Microbiol Rev. 2000;13:615-50.
5. Grueger T, Moerler C, Schnitzler N, Brandenburg K, Nidermajer S, Horré R, et al. Influence of fluoroquinolones on phagocytosis and killing of Candida albicans by human polymorphonuclear neutrophils. Med Mycol. 2008;46:675-84.
6. Azuma Y, Shinohara M, Wang PL, Ohura K. Quinolones alter defense reactions mediated by macrophages. Int Immunopharmacol. 2001;1:179-87. (Pubitemid 32183717)
7. Cacchillo DA, Walters JD. Effect of ciprofloxacin on killing of Actinobacillus actinomycetemcomitans by polymorphonuclear leukocytes. Antimicrob Agents Chemother. 2002;46:1980-4. (Pubitemid 34535226)
8. Fischer S, Adam D. Effects of moxifloxacin on neutrophil phagocytosis, burst production and killing as determined by a whole-blood cytofluorometric method. Antimicrob Agents Chemother. 2001;45:2668-9.
9. Yoshida S, Kojima T, Inoue M, Mitsuhashi S. Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother. 1991;35:368-70.
10. Kojima T, Inoue M, Mitsuhashi S. In vitro activity of AT-4140 against clinical bacterial isolates. Antimicrob Agents Chemother. 1989;33:1980-8.
11. Gajjar DA, Bello A, Ge Z, Christopher L, Grasela DM. Multipledose safety and pharmacokinetics of oral garenoxacin in healthy subjects. Antimicrob Agents Chemother. 2003;47:2256-63. (Pubitemid 36753581)
12. Schnitzler N, Haase G, Bussing A, Kaufhold A, Beyhs P, Podbielski A. Measuring resistance to phagocytosis of group A and G streptococci: comparison of direct bactericidal assay and flow cytometry. Med Microbiol Immunol. 1995;184:17-22.
13. Brown EJ. Complement receptors and phagocytosis. Curr Opin Immunol. 1991;3:76-82.
14. Rothe G, Emmendorffer A, Oser A, Roesler J, Valet G. Flow cytometric measurement of the respiratory burst activity of phagocytes using dihydrorhodamine 123. J Immunol Methods. 1991;138:133-5.
15. Dalhoff A. Immunomodulatory activities of fluoroquinolones. Infection. 2005;33(Suppl. 2):55-70.